Hematology/Oncology

Top Story

Corticosteroids, IV antibiotics increase risk for chemotherapy-induced febrile neutropenia

January 17, 2019
In the Journals Plus

Some patients with renal cancer may not benefit from partial nephrectomy

January 17, 2019
Although partial nephrectomy was associated with improved OS among patients with
In the Journals

Medicare Part B to D shift may decrease total spending, increase out-of-pocket costs

January 17, 2019
Although a proposal by the HHS to shift certain prescription drugs from Medicare Part B to Part D may reduce total drug spending by 6.9% to 18.3%, it could also increase…
In the Journals Plus

Higher platelet transfusion threshold increased risk for death among neonates with severe thrombocytopenia

January 16, 2019
Higher platelet transfusion threshold appeared to increase risk for death and major bleeding among preterm infants with severe thrombocytopenia, according to results of…
In the Journals Plus

Oncologists demonstrate limited knowledge about needs of LGBTQ patients but want more education

January 16, 2019
Oncologists at NCI-designated cancer centers demonstrated limited knowledge about the unique health needs of lesbian, gay, bisexual, transgender and queer/questioning…
More Headlines »
CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Video
Meeting News

VIDEO: WATS3D brush helps diagnose aggressive precancerous esophageal lesions

October 11, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next